These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19498298)

  • 1. Purulent pericarditis in a dog administered immune-suppressing drugs.
    Mohri T; Takashima K; Yamane T; Sato H; Yamane Y
    J Vet Med Sci; 2009 May; 71(5):669-72. PubMed ID: 19498298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive therapy for canine immune-mediated hemolytic anemia.
    Al-Ghazlat S
    Compend Contin Educ Vet; 2009 Jan; 31(1):33-41, 44; quiz 44. PubMed ID: 19241356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.
    Elwood C; Polton G
    J Vet Intern Med; 2008; 22(5):1075. PubMed ID: 18844828
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of idiopathic immune-mediated hemolytic anemia with mycophenolate mofetil in five dogs.
    West LD; Hart JR
    J Vet Emerg Crit Care (San Antonio); 2014; 24(2):226-31. PubMed ID: 24251650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic candidiasis in a dog, developing spondylitis.
    Kuwamura M; Ide M; Yamate J; Shiraishi Y; Kotani T
    J Vet Med Sci; 2006 Oct; 68(10):1117-9. PubMed ID: 17085895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Three months of prednisolone is enough treatment for IHA].
    Haneveld JK
    Tijdschr Diergeneeskd; 2011 Sep; 136(9):654-5. PubMed ID: 21939018
    [No Abstract]   [Full Text] [Related]  

  • 7. Canine immune-mediated hemolytic anemia: pathophysiology, clinical signs, and diagnosis.
    Balch A; Mackin A
    Compend Contin Educ Vet; 2007 Apr; 29(4):217-25. PubMed ID: 17726851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of evidence of a beneficial effect of azathioprine in dogs treated with prednisolone for idiopathic immune-mediated hemolytic anemia: a retrospective cohort study.
    Piek CJ; van Spil WE; Junius G; Dekker A
    BMC Vet Res; 2011 Apr; 7():15. PubMed ID: 21489250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of immunosuppressive regimens for immune-mediated haemolytic anaemia: a retrospective study of 42 dogs.
    Swann JW; Skelly BJ
    J Small Anim Pract; 2011 Jul; 52(7):353-8. PubMed ID: 21668886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune-mediated hemolytic anemia: 70 cases (1988-1996).
    Reimer ME; Troy GC; Warnick LD
    J Am Anim Hosp Assoc; 1999; 35(5):384-91. PubMed ID: 10493413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A suspected case of a multiple autoimmune syndrome in a poodle dog.
    Lim D; Jin Y; Son Y; Oh T; Bae S
    Vet Med Sci; 2022 Mar; 8(2):431-436. PubMed ID: 35137556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of prognostic factors, survival rates, and treatment protocols for immune-mediated hemolytic anemia in dogs: 151 cases (1993-2002).
    Weinkle TK; Center SA; Randolph JF; Warner KL; Barr SC; Erb HN
    J Am Vet Med Assoc; 2005 Jun; 226(11):1869-80. PubMed ID: 15934255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous Alternaria infectoria infection in a dog in association with therapeutic immunosuppression for the management of immune-mediated haemolytic anaemia.
    Dedola C; Stuart AP; Ridyard AE; Else RW; van den Broek AH; Choi JS; de Hoog GS; Thoday KL
    Vet Dermatol; 2010 Dec; 21(6):626-34. PubMed ID: 20500496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunosuppressive therapy in dogs and cats. Properties of drugs and their use in various immune-mediated diseases].
    Rieder J; Mischke R
    Tierarztl Prax Ausg K Kleintiere Heimtiere; 2018 Apr; 46(2):105-118. PubMed ID: 29727898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of immune-mediated hemolytic anemia in dogs with cyclophosphamide.
    Burgess K; Moore A; Rand W; Cotter SM
    J Vet Intern Med; 2000; 14(4):456-62. PubMed ID: 10935898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune-mediated haemolytic anaemia: possible association with Ancylostoma caninum infection in three dogs.
    Lobetti RG; Schoeman T
    J S Afr Vet Assoc; 2001 Mar; 72(1):52-4. PubMed ID: 11563722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic immune-mediated hemolytic anemia: treatment outcome and prognostic factors in 149 dogs.
    Piek CJ; Junius G; Dekker A; Schrauwen E; Slappendel RJ; Teske E
    J Vet Intern Med; 2008; 22(2):366-73. PubMed ID: 18346140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of enoxaparin in dogs with primary immune-mediated hemolytic anemia: 21 cases.
    Panek CM; Nakamura RK; Bianco D
    J Vet Emerg Crit Care (San Antonio); 2015; 25(2):273-7. PubMed ID: 25773906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentially antigenic RBC membrane proteins in dogs with primary immune-mediated hemolytic anemia.
    Tan E; Bienzle D; Shewen P; Kruth S; Wood D
    Vet Clin Pathol; 2012 Mar; 41(1):45-55. PubMed ID: 22315967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Splenectomy as an adjunctive treatment for dogs with immune-mediated hemolytic anemia: ten cases (2003-2006).
    Horgan JE; Roberts BK; Schermerhorn T
    J Vet Emerg Crit Care (San Antonio); 2009 Jun; 19(3):254-61. PubMed ID: 19691510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.